Recent Finacing
Recent Raise
Amlogenyx Inc., an Ultragenyx subsidiary, develops gene-therapy and enzyme-based treatments for Alzheimer’s and amyloid diseases, advancing a St. Jude-collaborated protease candidate that degrades Aβ42.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
